Is Axcella Health Inc. (AXLA) a Buy, Sell, or Hold?
Axcella Health Inc.
NASDAQ:AXLA
$4.58 USD
$0 (0.0%)
- Volume
- 6.78K
- Average Volume
- 37.08K
- Market Capitalization
- $12.5M
- P/E Ratio
- -3.61
- Dividend Yield
- 0.00%
- Price Target
- $60.00
- Year High
- $4.58
- Year Low
- $0.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.21
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
38
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
14
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 302.25K
AXLA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
AXLA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Koziel Margaret | officer: Chief Medical Officer | 2023-03-01 | S-Sale | 0.58 | 2023-03-03 |
| Koziel Margaret | officer: Chief Medical Officer | 2023-02-17 | A-Award | 0.6759 | 2023-02-24 |
| Hinshaw William | director, officer: President & CEO | 2023-02-17 | A-Award | 0.6759 | 2023-02-24 |
| Fehlner Paul | officer: SVP & Chief Legal Officer | 2023-02-17 | A-Award | 0.6759 | 2023-02-24 |
| Fehlner Paul | officer: SVP & Chief Legal Officer | 2023-02-10 | S-Sale | 0.6602 | 2023-02-13 |
| NISSEN TORBEN STRAIGHT | director | 2022-11-16 | A-Award | 0 | 2022-11-18 |
| Rosiello Robert L. | director | 2022-11-16 | A-Award | 0 | 2022-11-18 |
| Hinshaw William | officer: President & CEO | 2022-10-17 | A-Award | 0 | 2022-10-19 |
| Hinshaw William | officer: President & CEO | 2022-10-19 | S-Sale | 1.5642 | 2022-10-19 |
| AFEYAN NOUBAR | director | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| AFEYAN NOUBAR | director | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| AFEYAN NOUBAR | director | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| AFEYAN NOUBAR | director | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| AFEYAN NOUBAR | director | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Flagship Pioneering Inc. | director | 2022-10-13 | 0 | 2022-10-17 | |
| Rosiello Robert L. | None | 2022-10-10 | None | 2022-10-17 | |
| Rosiello Robert L. | director: | 2022-10-10 | 0 | 2022-10-17 | |
| NISSEN TORBEN STRAIGHT | None | 2022-10-10 | None | 2022-10-17 | |
| NISSEN TORBEN STRAIGHT | director: | 2022-10-10 | 0 | 2022-10-17 | |
| Societe des Produits Nestle S.A. | 10 percent owner | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| NESTLE SA | director | 2022-10-13 | P-Purchase | 1.64 | 2022-10-17 |
| Epstein David R | director: | 2022-05-19 | A-Award | 0 | 2022-06-03 |
| Koziel Margaret | officer: Chief Medical Officer | 2022-06-01 | S-Sale | 2.0107 | 2022-06-02 |
| SEKHRI PAUL J | director | 2022-05-19 | A-Award | 1.7 | 2022-05-25 |
| SEKHRI PAUL J | director: | 2022-05-19 | A-Award | 0 | 2022-05-25 |
| SEKHRI PAUL J | director: | 2022-05-19 | 0 | 2022-05-25 | |
| Hendrix Martin | director: | 2022-05-19 | A-Award | 0 | 2022-05-23 |
| Hendrix Martin | director: | 2022-05-19 | 0 | 2022-05-23 | |
| Sohn Catherine A. | director | 2022-05-19 | A-Award | 1.7 | 2022-05-23 |
| Sohn Catherine A. | director: | 2022-05-19 | A-Award | 0 | 2022-05-23 |
| Baird William D III | director: | 2022-05-19 | A-Award | 0 | 2022-05-23 |
| Baird William D III | director | 2022-05-19 | A-Award | 1.7 | 2022-05-23 |
| Rondinone CRISTINA | director | 2022-05-19 | A-Award | 1.7 | 2022-05-23 |
| Rondinone CRISTINA | director: | 2022-05-19 | A-Award | 0 | 2022-05-23 |
| Pisano Gary P. | director: | 2022-05-19 | A-Award | 0 | 2022-05-23 |
| Rosenblatt Michael | director | 2022-05-19 | A-Award | 1.7 | 2022-05-23 |
| Rosenblatt Michael | director: | 2022-05-19 | A-Award | 0 | 2022-05-23 |
| Rosenblatt Michael | director | 2022-05-19 | 0 | 2022-05-23 | |
| Rosenblatt Michael | director | 2022-05-19 | 6.21 | 2022-05-23 | |
| Rosenblatt Michael | director | 2022-05-19 | 13.83 | 2022-05-23 | |
| Rosenblatt Michael | director | 2022-05-19 | 6.52 | 2022-05-23 | |
| Epstein David R | director: | 2022-03-17 | A-Award | 0 | 2022-03-21 |
| Epstein David R | director: | 2022-03-17 | M-Exempt | 0 | 2022-03-21 |
| Crane Robert | officer: Chief Financial Officer | 2022-03-16 | A-Award | 0 | 2022-03-18 |
| Hinshaw William | officer: President & CEO | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Fehlner Paul | officer: SVP & Chief Legal Officer | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Epstein David R | director: | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Crane Robert | officer: Chief Financial Officer | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| AFEYAN NOUBAR | director: | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Flagship Ventures Fund IV General Partner LLC | 10 percent owner | 2022-03-16 | P-Purchase | 1.91 | 2022-03-18 |
| Societe des Produits Nestle S.A. | 10 percent owner | 2022-03-16 | P-Purchase | 1.91 | 2022-03-16 |
| NESTLE SA | director: | 2022-03-16 | P-Purchase | 1.91 | 2022-03-16 |
| Koziel Margaret | officer: Chief Medical Officer | 2022-03-01 | S-Sale | 1.8618 | 2022-03-03 |
| Crane Robert | officer: Chief Financial Officer | 2022-02-08 | 1.63 | 2022-02-28 | |
| Epstein David R | director | 2022-02-18 | M-Exempt | 0 | 2022-02-23 |
| Epstein David R | director | 2022-02-18 | M-Exempt | 0 | 2022-02-23 |
| Schecter Alison D. | officer: President - Research & Dev. | 2022-02-08 | A-Award | 1.63 | 2022-02-10 |
| Fehlner Paul | officer: SVP & Chief Legal Officer | 2022-02-08 | A-Award | 1.63 | 2022-02-10 |
| Hinshaw William | director, officer: President & CEO | 2022-02-08 | A-Award | 1.63 | 2022-02-10 |
| Hinshaw William | director, officer: President & CEO | 2022-02-08 | A-Award | 5 | 2022-02-10 |
| Koziel Margaret | officer: Chief Medical Officer | 2022-02-08 | A-Award | 1.63 | 2022-02-10 |
| Dean Virginia R | officer: SVP, Chief People Officer | 2022-02-08 | A-Award | 1.63 | 2022-02-10 |
| Hinshaw William | director, officer: President and CEO | 2022-01-28 | M-Exempt | 0 | 2022-02-01 |
| Hinshaw William | director, officer: President and CEO | 2022-01-31 | S-Sale | 1.6512 | 2022-02-01 |
| Hinshaw William | director, officer: President and CEO | 2022-01-28 | M-Exempt | 0 | 2022-02-01 |
| Epstein David R | director | 2022-01-18 | M-Exempt | 0 | 2022-01-20 |
| Epstein David R | director | 2022-01-18 | M-Exempt | 0 | 2022-01-20 |
| Epstein David R | director | 2021-12-17 | M-Exempt | 0 | 2021-12-20 |
| Epstein David R | director | 2021-12-17 | M-Exempt | 0 | 2021-12-20 |
| Schecter Alison D. | officer: President - Research & Dev. | 2021-12-10 | A-Award | 5.57 | 2021-12-14 |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-10 | A-Award | 2.6 | 2021-12-13 |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-01 | 0 | 2021-12-13 | |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-01 | 6.59 | 2021-12-13 | |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-01 | 9.31 | 2021-12-13 | |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-01 | 4.12 | 2021-12-13 | |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-01 | 5.04 | 2021-12-13 | |
| Koziel Margaret | officer: Chief Medical Officer | 2021-12-01 | 4.11 | 2021-12-13 | |
| Epstein David R | director | 2021-11-18 | M-Exempt | 0 | 2021-11-22 |
| Epstein David R | director | 2021-11-18 | M-Exempt | 0 | 2021-11-22 |
| Epstein David R | director | 2021-10-18 | M-Exempt | 0 | 2021-10-19 |
| Epstein David R | director | 2021-10-18 | M-Exempt | 0 | 2021-10-19 |
| Epstein David R | director | 2021-09-17 | M-Exempt | 0 | 2021-09-20 |
| Epstein David R | director | 2021-09-17 | M-Exempt | 0 | 2021-09-20 |
| Pisano Gary P. | director | 2021-08-13 | M-Exempt | 0.28 | 2021-08-25 |
| Pisano Gary P. | director | 2021-08-13 | M-Exempt | 0.28 | 2021-08-25 |
| Epstein David R | director | 2021-08-18 | M-Exempt | 0 | 2021-08-19 |
| Epstein David R | director | 2021-08-18 | M-Exempt | 0 | 2021-08-19 |
| Epstein David R | director | 2021-07-16 | M-Exempt | 0 | 2021-07-20 |
| Epstein David R | director | 2021-07-16 | M-Exempt | 0 | 2021-07-20 |
| Dean Virginia R | officer: SVP, Chief People Officer | 2021-06-22 | A-Award | 4.15 | 2021-06-25 |
| Dean Virginia R | officer | 2021-06-21 | 0 | 2021-06-25 | |
| Epstein David R | director | 2021-06-18 | M-Exempt | 0 | 2021-06-21 |
| Epstein David R | director | 2021-06-18 | M-Exempt | 0 | 2021-06-21 |